UNIVERSITY PARK, Pa. — Ibrahim Ozbolat, a professor of engineering science and mechanics and of biomedical engineering at Penn State, has been elected a fellow of the American Society of Mechanical Engineers (ASME).
According to the notification letter, the honor recognizes exceptional engineering achievements and contributions to the engineering profession and to ASME. It is a selective honor, with 3,448 fellows among the organization’s 70,255 members.
Ozbolat was recognized for his contributions to 3D bioprinting and regenerative medicine, advancing research at the intersection of engineering, biology and medicine, including innovations that support tissue engineering and cellular-level design approaches.
“Ibrahim Ozbolat’s election as a fellow is a tremendous and well-deserved recognition of his leadership in bioprinting and biofabrication,” said Vincent Meunier, the department head, P.B. Breneman Chair and professor of engineering science and mechanics. “His pioneering research has helped define a rapidly advancing field with profound implications for tissue engineering, regenerative medicine and human health. This honor reflects both the impact of his scientific contributions and the international visibility of his work. We are delighted to celebrate this achievement and proud to have him as a colleague at Penn State.”
ASME fellowship is one of the organization’s highest distinctions and reflects the society’s commitment to its vision “to be the premier resource for the engineering community globally,” according to the notification letter.
“Being elected as an ASME fellow is meaningful because it highlights the essential role of mechanical engineering in advancing 3D bioprinting technologies for living tissues and organs,” Ozbolat said. “This recognition will support my efforts to develop engineering-driven biofabrication platforms and precision bioprinting technologies that bridge mechanical engineering with regenerative medicine. It also reinforces the importance of mechanical engineering innovation in shaping the future of healthcare and artificial organ manufacturing.”